Select Medical Holdings (SEM) Cash & Equivalents (2018 - 2026)

Select Medical Holdings has disclosed Cash & Equivalents across 9 years of filings, most recently posting $25.7 million for Q1 2026.

• In Q1 2026, Cash & Equivalents fell 51.74% year-over-year to $25.7 million; the TTM figure through Mar 2026 stood at $25.7 million (down 51.74% YoY), while the FY2025 annual figure was $26.5 million, down 55.57% from the prior year.
• Cash & Equivalents slipped to $25.7 million in Q1 2026, from $26.5 million in the prior quarter.
• Over the last five years, Cash & Equivalents for SEM reached as high as $191.5 million in Q3 2024 and fell as low as $25.7 million in Q1 2026.
• The 5-year median for Cash & Equivalents is $83.7 million (2023), against an average of $83.5 million.
• Annual changes were most pronounced in 2022 — Cash & Equivalents tumbled 88.22% — and 2024, when it surged 147.25%.
• A 5-year view of Cash & Equivalents shows it stood at $97.9 million in 2022, then sank by 46.24% to $52.6 million in 2023, then increased by 13.42% to $59.7 million in 2024, then plunged by 55.57% to $26.5 million in 2025, then fell by 3.17% to $25.7 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $25.7 million, $26.5 million, and $60.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.